Results 121 to 130 of about 16,043 (285)

Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years [PDF]

open access: bronze, 2003
Maria Pitsiu   +5 more
openalex   +1 more source

Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model

open access: yesClinical Ophthalmology, 2018
Edward J Meier,1 Gail L Torkildsen,2 Paul J Gomes,3 Mark C Jasek4 1Apex Eye, Mason, OH, USA; 2Andover Eye, Andover, MA, USA; 3Allergy, Ora, Inc., Andover, MA, USA; 4Eyevance Pharmaceuticals, TX, USA Purpose: The purpose of these Phase III studies was ...
Meier EJ   +3 more
doaj  

Participation of Histamine H3 Receptors in Experimental Allergic Rhinitis of Mice

open access: yesJournal of Pharmacological Sciences, 2008
The present study was performed to study the participation of histamine H3 receptors in nasal symptoms using Sch 50971, a potent and selective agonist of the H3 receptor.
Emiko Yokota   +4 more
doaj  

Effect of antihistamine up-dosing in chronic urticaria [PDF]

open access: yes, 2011
Chronic urticaria has an important impact upon patient quality of life, and no treatment has yet been developed capable of effectively controlling the disease.
Bartra, J. (J.)   +8 more
core  

The molecular behaviour of cetirizine

open access: yesClinical & Experimental Allergy, 1997
Testa, Bernard   +2 more
openaire   +4 more sources

The effect of cetirizine, an H1 receptor antagonist, on bone modeling during orthodontic tooth movement in rats [PDF]

open access: hybrid, 2009
Alja Meh   +5 more
openalex   +1 more source

Cetirizine‐induced anaphylaxis: a rare adverse drug reaction [PDF]

open access: green, 2009
Nisha Afonso   +3 more
openalex   +1 more source

Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients

open access: yesPulmonary Pharmacology & Therapeutics, 2020
Reed B. Hogan II   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy